THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Vittalle (Online) |
Texto Completo: | https://periodicos.furg.br/vittalle/article/view/13950 |
Resumo: | The direct link between the gut-brain axis is increasingly debated as an important factor in the development of mental illness, particularly in major depressive disorder. There is a bidirectional communication axis between brain and gut, where abnormalities in the gut microbiota affect the brain and behavior. In this sense, disturbances in the intestinal microbiota, which favor dysbiosis, are considered a risk factor for depressive disorder, and the regulation of this can be a method of therapy and prevention of depression. The present study analyzed the impact of probiotic treatment for major depressive disorder through an integrative literature review of clinical trials published in the last 5 years. In total, 8 articles were selected, in which the studied bacteria belong to the Bifidobacterium, Lactobacillus and Lactococcus genera. The articles indicate that intervention with probiotics acts in major depressive disorder through three mechanisms of action. The first refers to the production of short-chain fatty acids, reducing intestinal pH and slowing the growth of pathogenic bacteria. Promoting the synthesis of IgA which protects the intestinal barrier, preventing the passage of LPS into the circulation, decreasing systemic inflammation. Finally, by increasing the plasma levels of tryptophan and decreasing the concentration of kynurenine, consequently improving the production of serotonin. Thus, the care about the intestinal microbiota and the use of probiotics can help in the treatment of depressive disorders and also in the prevention, acting as a new therapeutic option. |
id |
FURG-6_b3cdec40c6832002f9ddda23f64eea89 |
---|---|
oai_identifier_str |
oai:periodicos.furg.br:article/13950 |
network_acronym_str |
FURG-6 |
network_name_str |
Vittalle (Online) |
repository_id_str |
|
spelling |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIESO papel da microbiota intestinal nos transtornos depressivos: uma revisão sobre o tema e estudos clínicosProbióticostranstorno depressivo maioreixo microbiota-intestino-cérebrodisbioseThe direct link between the gut-brain axis is increasingly debated as an important factor in the development of mental illness, particularly in major depressive disorder. There is a bidirectional communication axis between brain and gut, where abnormalities in the gut microbiota affect the brain and behavior. In this sense, disturbances in the intestinal microbiota, which favor dysbiosis, are considered a risk factor for depressive disorder, and the regulation of this can be a method of therapy and prevention of depression. The present study analyzed the impact of probiotic treatment for major depressive disorder through an integrative literature review of clinical trials published in the last 5 years. In total, 8 articles were selected, in which the studied bacteria belong to the Bifidobacterium, Lactobacillus and Lactococcus genera. The articles indicate that intervention with probiotics acts in major depressive disorder through three mechanisms of action. The first refers to the production of short-chain fatty acids, reducing intestinal pH and slowing the growth of pathogenic bacteria. Promoting the synthesis of IgA which protects the intestinal barrier, preventing the passage of LPS into the circulation, decreasing systemic inflammation. Finally, by increasing the plasma levels of tryptophan and decreasing the concentration of kynurenine, consequently improving the production of serotonin. Thus, the care about the intestinal microbiota and the use of probiotics can help in the treatment of depressive disorders and also in the prevention, acting as a new therapeutic option.A ligação direta do eixo intestino-cérebro é cada vez mais debatida como um fator importante no desenvolvimento das doenças mentais, principalmente no transtorno depressivo maior. Há um eixo de comunicação bidirecional entre cérebro e intestino, onde anormalidades na microbiota intestinal afetam o cérebro e o comportamento. Neste sentido, as perturbações na microbiota intestinal, que favorecem a disbiose, são consideradas fator de risco chave para o transtorno depressivo, e a regulação desta é um método de terapia e prevenção da depressão. O presente estudo analisou o impacto do tratamento com probióticos no desenvolvimento do transtorno depressivo maior, por meio de uma revisão bibliográfica integrativa de estudos clínicos publicados nos últimos 5 anos. Ao total, foram selecionados 8 artigos, nos quais as bactérias estudadas pertencem aos gêneros Bifidobacterium, Lactobacillus e Lactococcus. Os artigos apontam que a intervenção com probióticos atua no transtorno depressivo maior por três mecanismos de ação. Referindo-se a produção de ácidos graxos de cadeia curta, reduzindo o pH intestinal e retardando o crescimento de bactérias patogênicas. Promovendo a síntese de IgA a qual protege a barreira intestinal, impedindo a passagem de LPS para a circulação, diminuindo a inflamação sistêmica. Por fim, através do aumento dos níveis plasmáticos de triptofano e a diminuição da concentração de quinurenina, consequentemente melhorando a produção de serotonina. Assim, o cuidado com a microbiota intestinal e o uso de probióticos pode auxiliar no tratamento de transtornos depressivos e também na prevenção, atuando como uma nova opção terapêutica.Universidade Federal do Rio Grande2022-12-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.furg.br/vittalle/article/view/1395010.14295/vittalle.v34i3.13950VITTALLE - Revista de Ciências da Saúde; v. 34 n. 3 (2022); 8-192177-78531413-3563reponame:Vittalle (Online)instname:Universidade Federal do Rio Grande (FURG)instacron:FURGporhttps://periodicos.furg.br/vittalle/article/view/13950/9978Copyright (c) 2022 VITTALLE - Revista de Ciências da Saúdeinfo:eu-repo/semantics/openAccessKasprowicz, Julia Nahir Savi, Daiani Cristina2022-12-22T20:52:16Zoai:periodicos.furg.br:article/13950Revistahttps://periodicos.furg.br/vittallePUBhttps://periodicos.furg.br/vittalle/oaivittalle@furg.br2177-78531413-3563opendoar:2022-12-22T20:52:16Vittalle (Online) - Universidade Federal do Rio Grande (FURG)false |
dc.title.none.fl_str_mv |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES O papel da microbiota intestinal nos transtornos depressivos: uma revisão sobre o tema e estudos clínicos |
title |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES |
spellingShingle |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES Kasprowicz, Julia Nahir Probióticos transtorno depressivo maior eixo microbiota-intestino-cérebro disbiose |
title_short |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES |
title_full |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES |
title_fullStr |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES |
title_full_unstemmed |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES |
title_sort |
THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES |
author |
Kasprowicz, Julia Nahir |
author_facet |
Kasprowicz, Julia Nahir Savi, Daiani Cristina |
author_role |
author |
author2 |
Savi, Daiani Cristina |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Kasprowicz, Julia Nahir Savi, Daiani Cristina |
dc.subject.por.fl_str_mv |
Probióticos transtorno depressivo maior eixo microbiota-intestino-cérebro disbiose |
topic |
Probióticos transtorno depressivo maior eixo microbiota-intestino-cérebro disbiose |
description |
The direct link between the gut-brain axis is increasingly debated as an important factor in the development of mental illness, particularly in major depressive disorder. There is a bidirectional communication axis between brain and gut, where abnormalities in the gut microbiota affect the brain and behavior. In this sense, disturbances in the intestinal microbiota, which favor dysbiosis, are considered a risk factor for depressive disorder, and the regulation of this can be a method of therapy and prevention of depression. The present study analyzed the impact of probiotic treatment for major depressive disorder through an integrative literature review of clinical trials published in the last 5 years. In total, 8 articles were selected, in which the studied bacteria belong to the Bifidobacterium, Lactobacillus and Lactococcus genera. The articles indicate that intervention with probiotics acts in major depressive disorder through three mechanisms of action. The first refers to the production of short-chain fatty acids, reducing intestinal pH and slowing the growth of pathogenic bacteria. Promoting the synthesis of IgA which protects the intestinal barrier, preventing the passage of LPS into the circulation, decreasing systemic inflammation. Finally, by increasing the plasma levels of tryptophan and decreasing the concentration of kynurenine, consequently improving the production of serotonin. Thus, the care about the intestinal microbiota and the use of probiotics can help in the treatment of depressive disorders and also in the prevention, acting as a new therapeutic option. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.furg.br/vittalle/article/view/13950 10.14295/vittalle.v34i3.13950 |
url |
https://periodicos.furg.br/vittalle/article/view/13950 |
identifier_str_mv |
10.14295/vittalle.v34i3.13950 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.furg.br/vittalle/article/view/13950/9978 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 VITTALLE - Revista de Ciências da Saúde info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 VITTALLE - Revista de Ciências da Saúde |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal do Rio Grande |
publisher.none.fl_str_mv |
Universidade Federal do Rio Grande |
dc.source.none.fl_str_mv |
VITTALLE - Revista de Ciências da Saúde; v. 34 n. 3 (2022); 8-19 2177-7853 1413-3563 reponame:Vittalle (Online) instname:Universidade Federal do Rio Grande (FURG) instacron:FURG |
instname_str |
Universidade Federal do Rio Grande (FURG) |
instacron_str |
FURG |
institution |
FURG |
reponame_str |
Vittalle (Online) |
collection |
Vittalle (Online) |
repository.name.fl_str_mv |
Vittalle (Online) - Universidade Federal do Rio Grande (FURG) |
repository.mail.fl_str_mv |
vittalle@furg.br |
_version_ |
1797041721534578688 |